High-dose interleukin-2 is an intensive treatment regardless of the  venue of administration.
Schwartzentruber
D J
DJ
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy*
D007376:Interleukin-2